Eric Levine, MD | |
535 Faunce Corner Rd, Dartmouth, MA 02747-1242 | |
(508) 996-3991 | |
Not Available |
Full Name | Eric Levine |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 34 Years |
Location | 535 Faunce Corner Rd, Dartmouth, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528038734 | NPI | - | NPPES |
3154416 | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 76157 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Southcoast Hospitals Group | Fall river, MA | Hospital |
Saint Anne's Hospital | Fall river, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Steward Medical Group Inc | 2860688728 | 1404 |
News Archive
Tiny particles filled with a drug could be a new tool for treating cancer in the future. A new study published by Swedish scientists in Particle & Particle Systems Characterization shows how such nanoparticles can be combined to secure the effective delivery of cancer drugs to tumour cells - and how they can be given properties to make them visible in MR scanners and thus rendered trackable.
Indian scientists suggest that people currently controlling their diabetes with daily insulin injections will soon be able to use an insulin pill instead.
Chiropractor and nutritional educator, Dr. Michael Dobbins, has received the Excellence in Nutritional Education award from Standard Process. The Wisconsin-based nutritional whole food supplement manufacturer presented the award during a private reception Thursday evening at Florida Chiropractic Association's National Convention and Expo event in Orlando, Fla.
Protalix Biotherapeutics, Inc. (NYSE-Amex: PLX), announced the completion of its pivotal Phase III trial for prGCD, the Company's proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The trial enrolled a total of 31 patients across Europe, North America, South America, Israel and South Africa. No serious adverse events were reported in this trial.
Prism Medical Ltd., a leading provider of durable medical equipment and related services to the mobility disadvantaged, today announced that the Company has been awarded a significant new contract to provide Disability Equipment Services for the London Borough of Bexley.
› Verified 6 days ago
Entity Name | Steward Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821349317 PECOS PAC ID: 2860688728 Enrollment ID: O20130626000396 |
News Archive
Tiny particles filled with a drug could be a new tool for treating cancer in the future. A new study published by Swedish scientists in Particle & Particle Systems Characterization shows how such nanoparticles can be combined to secure the effective delivery of cancer drugs to tumour cells - and how they can be given properties to make them visible in MR scanners and thus rendered trackable.
Indian scientists suggest that people currently controlling their diabetes with daily insulin injections will soon be able to use an insulin pill instead.
Chiropractor and nutritional educator, Dr. Michael Dobbins, has received the Excellence in Nutritional Education award from Standard Process. The Wisconsin-based nutritional whole food supplement manufacturer presented the award during a private reception Thursday evening at Florida Chiropractic Association's National Convention and Expo event in Orlando, Fla.
Protalix Biotherapeutics, Inc. (NYSE-Amex: PLX), announced the completion of its pivotal Phase III trial for prGCD, the Company's proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The trial enrolled a total of 31 patients across Europe, North America, South America, Israel and South Africa. No serious adverse events were reported in this trial.
Prism Medical Ltd., a leading provider of durable medical equipment and related services to the mobility disadvantaged, today announced that the Company has been awarded a significant new contract to provide Disability Equipment Services for the London Borough of Bexley.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Eric Levine, MD 535 Faunce Corner Rd, Dartmouth, MA 02747-1242 Ph: (508) 996-3991 | Eric Levine, MD 535 Faunce Corner Rd, Dartmouth, MA 02747-1242 Ph: (508) 996-3991 |
News Archive
Tiny particles filled with a drug could be a new tool for treating cancer in the future. A new study published by Swedish scientists in Particle & Particle Systems Characterization shows how such nanoparticles can be combined to secure the effective delivery of cancer drugs to tumour cells - and how they can be given properties to make them visible in MR scanners and thus rendered trackable.
Indian scientists suggest that people currently controlling their diabetes with daily insulin injections will soon be able to use an insulin pill instead.
Chiropractor and nutritional educator, Dr. Michael Dobbins, has received the Excellence in Nutritional Education award from Standard Process. The Wisconsin-based nutritional whole food supplement manufacturer presented the award during a private reception Thursday evening at Florida Chiropractic Association's National Convention and Expo event in Orlando, Fla.
Protalix Biotherapeutics, Inc. (NYSE-Amex: PLX), announced the completion of its pivotal Phase III trial for prGCD, the Company's proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The trial enrolled a total of 31 patients across Europe, North America, South America, Israel and South Africa. No serious adverse events were reported in this trial.
Prism Medical Ltd., a leading provider of durable medical equipment and related services to the mobility disadvantaged, today announced that the Company has been awarded a significant new contract to provide Disability Equipment Services for the London Borough of Bexley.
› Verified 6 days ago
Jack A Howard, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 | |
Dr. Maria Pacheco Rumsey, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 | |
Hugo G Jauregui, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 | |
Thomas M Vallone, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 | |
Hanumara Ram Chowdri, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 | |
James Peter Tracey, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 | |
Dr. John Niedzwicki, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |